Equol, first isolated from equine urine in 1932 and identified 50 years later in human urine
as a metabolite of the soy isoflavones, daidzin and daidzein, is produced by intestinal …

The health effects of (poly) phenols (PPs) depend upon their bioavailability that, in general,
is very low and shows a high interindividual variability. The low bioavailability of PPs is …

Background: The discovery of equol in human urine more than 2 decades ago and the
finding that it is bacterially derived from daidzin, an isoflavone abundant in soy foods, led to …

The indigenous intestinal microflora are involved in a variety of processes within the human
body, and are important for maintaining host health. As such, interindividual differences in …

Evidence that the intestinal microbiota is intrinsically linked with overall health, including
cancer risk, is emerging. Moreover, its composition is not fixed but can be influenced by …

Several foods are rich sources of phenolic compounds (PC) and their beneficial effects on
human health may be increased through the action of probiotics. Additionally, probiotics may …

Hydroxy-3-(4′-hydroxyphenyl)-chroman (S-equol) is a specific end-metabolite formed in
the biotransformation of the dietary soy isoflavones daidzin and daidzein by intestinal …

Soy isoflavones have received considerable attention. Individuals with isoflavones‐rich diets
have significantly lower occurrences of cardiovascular disease, osteoporosis, and some …

The human gut microbiota has a significant effect on many aspects of human physiology
such as metabolism, nutrient absorption, and immune function. Imbalance of the microbiota …

Objective: To assess the efficacy of probiotic therapies on body weight and BMI using a meta-
analysis of randomized, controlled trials. Methods: Twenty studies with 25 trials (1931 …